Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| (Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious Puberty | endocrine system disorder, gonadal disorder, precocious puberty | Not yet recruiting | Phase 2 | 2026-10-09 | NCT07869732 | |
| (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, invasive breast carcinoma, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-07-08 | NCT05607004 |